Navigation Links
Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
Date:4/29/2013

>

Not satisfied with EMLA as a PE treatment, Dr. Gilbert sought a fast-acting, lidocaine-only topical medication with superior skin absorption capability, no loss of penile sexual sensation, elimination of partner transfer, and minimal side effects.  After five years of analysis and laboratory work, Dr. Gilbert and colleagues developed a formulation containing lidocaine, thymol and ethanol in specific ratios that improved EMLA's eutectic absorption effect. This novel formulation also achieved the maximum absorption rate of lidocaine through penile stratum corneum (skin's outer layer), and thus attained maximum anesthetic effect, but retained great sensory feeling. Virtually no transfer of the anesthetic effect to the patient's partner has been reported, and prilocaine side effects have been eliminated. The secret to the new formulation lies in the strict proprietary balance of ingredient concentrations that maximized the effect of lidocaine's anesthetic efficacy.

"Dr. Gilbert was a superb and compassionate physician and after seeing so many men suffering from PE, he dedicated much of his professional career to finding a safe, easy-to-use, and inexpensive solution," says Jeff Abraham , CEO of Absorption Pharmaceuticals.

Available over-the-counter under FDA Monograph 21 CFR 348.10, Promescent is gaining acceptance by urologists and general practitioners across the U.S. The award of this patent strengthens Absorption Pharmaceuticals position as a leader in the treatment of premature ejaculation.

About Absorption Pharmaceuticals

Absorption Pharmaceuticals is the maker of Promescent, the world's first FDA-approved topical treatment for premature ejaculation. Based in Huntington Beach, California, the company was founded in 2011 and has seen tremendous growth including distribu
'/>"/>

SOURCE Absorption Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Absorption Systems announces novel test platform for interactions with the BCRP transporter
2. Absorption Systems Registers with FDA as a Generic Drug Facility under GDUFA
3. Absorption Systems Partners with Synerzys to Promote Biopharmaceutics Classification System (BCS) Testing of Drugs
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
8. Icahn Issues Statement Regarding Amylin Pharmaceuticals
9. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
10. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
11. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , August 28, 2015 The report "Eubiotics ... (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by Region ( ... Asia-Pacific , and Rest of the World) - ... global market for Eubiotics was valued at USD 4.62 Billion ... by 2020, at a CAGR of 7.4% from 2015 to ...
(Date:8/28/2015)... and LONDON , August 28, 2015 /PRNewswire/ ... approach seamlessly connects people, technologies and ... improving outcomes and the cost of healthcare ... AEX: PHIA) today announced its presence at  ESC Congress 2015 ... including Heart Model A.I. , EchoNavigator and IntelliSpace Cardiovascular, that ...
(Date:8/27/2015)... ALEXANDRIA, Va. , Aug. 27, 2015 /PRNewswire-USNewswire/ ... in the Food and Drug Administration,s (FDA,s) draft ... including reference products and biosimilars, to bear a ... years, AMCP has been seeking a decision from ... joined 18 diverse health care stakeholders urging the ...
Breaking Medicine Technology:Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
... ADDISON, Texas, May 11, 2011 ULURU Inc. ... scheduled a conference call to discuss the first quarter ended March ... on Tuesday, May 17, 2011 at 9:00 a.m. Eastern Time. ... for international callers dial (850) 429-1388 (access code 23748#) five to ...
... May 11, 2011 HCB Health, one of the ... and the leading healthcare agency in the Southwest, won ... the 22nd annual Manny Awards, a national competition honoring ... for a consumer campaign supporting Sound Surgical Technologies, VASER® ...
Cached Medicine Technology:ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2011 and to Provide a Business Update 2HCB Health Wins Manny Award for Best Medical Device Campaign 2
(Date:8/29/2015)... ... 29, 2015 , ... "I have been a licensed physical ... specialize in manual therapy, and my invention will provide headache sufferers a solution ... muscle dysfunction throughout the body." , They developed THE RELIEVER to alleviates headaches, ...
(Date:8/29/2015)... ... August 29, 2015 , ... Brands like Toppik , ... standard shipping costs. , “Before, a threshold of $49.00 was required to qualify for ... items qualify for free standard shipping for customers regardless of the item’s selling price.” ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring strain ... with stretching, soft tissue manipulation. Platelet rich plasma injections also have mixed ... to improve treatment outcomes. This localized treatment seems to address the symptoms ...
(Date:8/28/2015)... ... 28, 2015 , ... Joining a growing number of hospitals ... management companies to partner with Wound Care Advantage (WCA) to utilize the ... , Transitioning wound care management providers can be a complex undertaking. WCA provides ...
(Date:8/28/2015)... ... August 28, 2015 , ... An article ... pizza maker Paul LaRocco has gone through to open a pizzeria in Westchester. Mr. ... process tends to take several months, but the current process, having already gone on ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2
... is pleased to announce the introduction of TPC Transition ... enable hospitals to reduce the $17 billion cost associated ... gaps in follow-up care" according to a recently released ... TPC Transition Home enables hospitals to manage the transition ...
... N.J., May 7 MedQuist Inc., (Nasdaq: MEDQ ... leader in technology-enabled clinical documentation workflow, today announced its unaudited ... income for the first quarter of 2009 was $6.9 million, ... 2008 when a loss of $4.4 million was reported. Earnings ...
... MONTVALE, N.J. May 7 Acting in response to ... Dolce Hotels and Resorts (TM), a privately ... centers in North America and Europe, today announced a ... and employees and provide reassurance about the safety of ...
... Trey Anastasio, lead singer of the rock band Phish ... May 6, to participate in a day-long celebration marking the ... Association of Drug Court Professionals (NADCP) in calling for a ... Anastasio recognized over fifteen members of Congress for their support ...
... OAKLAND, Calif., May 7 In a major victory ... the 440,000 seniors and people with disabilities who rely ... ruled that proposed cuts to the IHSS program violate ... (ARRA) . The ruling came after the Service ...
... May 7 The following is a statement from ... of the American Public Health Association:"The American Public Health ... the investments in health included in President Obama,s FY ... care reserve fund which will be used to finance ...
Cached Medicine News:Health News:TouchPointCare Introduces TPC Transition Home to Help Hospitals Reduce Unplanned Readmissions 2Health News:MedQuist Reports First Quarter 2009 Results 2Health News:MedQuist Reports First Quarter 2009 Results 3Health News:MedQuist Reports First Quarter 2009 Results 4Health News:MedQuist Reports First Quarter 2009 Results 5Health News:MedQuist Reports First Quarter 2009 Results 6Health News:MedQuist Reports First Quarter 2009 Results 7Health News:MedQuist Reports First Quarter 2009 Results 8Health News:MedQuist Reports First Quarter 2009 Results 9Health News:Dolce Hotels and Resorts Initiates Program to Mitigate H1N1 Flu Risk 2Health News:Phish Frontman Trey Anastasio Visits Capitol Hill to Support Drug Courts and Calls on Congress to Put a Drug Court Within Reach of Every American in Need 2Health News:Phish Frontman Trey Anastasio Visits Capitol Hill to Support Drug Courts and Calls on Congress to Put a Drug Court Within Reach of Every American in Need 3Health News:Obama Administration Rules Against California's Proposed Wage Cuts to Homecare Workers 2Health News:APHA Applauds Health Reform Fund and Other Health Investments in Budget 2
... Impulse II lead series are silicon ... extend the longevity of the pacemaker ... The high impedance of the lead ... electrode surface, combined with the elution ...
CapSure SP Novus endocardial, tined pacing leads provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but within an even smaller...
The Vitatron Slimtine S lead series are endocardial leads with an excellent history of reliability and optimal handling en pacing performance....
Selute Picotip Atrial-J steroid eluting passive fixation lead...
Medicine Products: